Drug Trial Radar · NCT01408303
[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL
Last checked: Nov 20, 2026Latest source record: Dec 5, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
646
Actual
Start
Aug 2011
Primary completion
Jun 2012
Study completion Jun 2012
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Omthera Pharmaceuticals, Inc; Medpace, Inc.
- First posted
- Aug 3, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to evaluate the efficacy of adding Epanova (2 g or 4 g daily) to an optimal statin monotherapy for lowering non-high-density lipoprotein (non-HDL) cholesterol in subjects with persistent hypertriglyceridemia and high risk for cardiovascular disease.
Conditions
- Hypertriglyceridemia
- Cardiovascular Disease
Interventions
Olive oil, 4gDrug
Olive oil: 4 x 1 g capsule daily for 6 weeks + prescription statin
omega-3-carboxylic acids, 2gDrug
Epanova: 2 x 1 g capsule + olive oil 2 x 1 g capsule daily for 6 weeks + prescription statin
omega-3-carboxylic acids, 4gDrug
Epanova: 4 x 1 g capsule daily for 6 weeks + prescription statin
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serum Non-HDL CholesterolTime frame: 6 weeks
Locations
89 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Muscle Shoals, Alabama
Site not named
Chandler, Arizona
Site not named
Phoenix, Arizona
Site not named
Little Rock, Arkansas
Site not named
Encinitas, California
Site not named
Lomita, California
Site not named
Los Angeles, California
Site not named
Sacramento, California
Site not named
San Diego, California
Site not named
Spring Valley, California
Site not named
Westlake Village, California
Site not named
Colorado Springs, Colorado
Site not named
Denver, Colorado
Site not named
Brandon, Florida
Site not named
Clearwater, Florida
Site not named
Coral Gables, Florida
Site not named
Hialeah, Florida
Site not named
Jacksonville, Florida
Site not named
Jacksonville, Florida
Site not named
Jupiter, Florida
Site not named
Melbourne, Florida
Site not named
Miami, Florida
Site not named
Miami, Florida
Site not named
Miami, Florida
Site not named
New Port Richey, Florida
Site not named
Ocala, Florida
Site not named
Orlando, Florida
Site not named
Oviedo, Florida
Site not named
Ponte Vedra, Florida
Site not named
St. Petersburg, Florida
Site not named
Addison, Illinois
Site not named
Chicago, Illinois
Site not named
Oakbrook Terrace, Illinois
Site not named
Indianapolis, Indiana
Site not named
Newton, Kansas
Site not named
Wichita, Kansas
Site not named
Wichita, Kansas
Site not named
Louisville, Kentucky
Site not named
Madisonville, Kentucky
Site not named
Auburn, Maine
Showing 40 of 89 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.